Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
229.14
0.00
(0.00%)
As of February 25 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
7,771,000
7,771,000
7,380,000
3,912,000
2,228,000
Investing Cash Flow
-9,907,000
-9,907,000
-1,282,000
-2,761,000
-961,000
Financing Cash Flow
-3,919,000
-3,919,000
-606,000
-789,000
-420,000
End Cash Position
9,858,000
9,858,000
14,867,000
9,893,000
8,957,000
Capital Expenditure
-304,000
-304,000
-376,000
-317,000
-252,000
Repayment of Debt
-60,000
-60,000
-91,000
-73,000
-58,000
Repurchase of Capital Stock
-3,879,000
-3,879,000
-564,000
-908,000
-447,000
Free Cash Flow
7,467,000
7,467,000
7,004,000
3,595,000
1,976,000
12/31/2021 - 1/5/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MOC.WA Molecure S.A.
9.00
+1.69%
NV3P.F NanoViricides, Inc.
1.1300
-11.72%
MAGLE.ST Magle Chemoswed Holding AB (publ)
32.40
0.00%
RGO.DU Regeneron Pharmaceuticals Inc
684.00
+1.33%
HQ1.MU Oruka Therapeutics Inc. R
10.30
-2.83%
PH4.F CStone Pharmaceuticals
0.4320
+1.89%
CHOSA.ST CHOSA Oncology AB
0.9000
+28.57%
BSSP Baseline Productions, Inc.
0.0001
0.00%
SBHMY Sino Biopharmaceutical Limited
8.06
0.00%
SBMFF Sino Biopharmaceutical Limited
0.4240
0.00%